ARYA SCIENCES ACQU CORP IV's ticker is ARYD and the CUSIP is G31659108. A total of 25 filers reported holding ARYA SCIENCES ACQU CORP IV in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,246,000 | +2.9% | 300,000 | 0.0% | 0.07% | +4.5% |
| Q2 2023 | $3,156,000 | +1.6% | 300,000 | 0.0% | 0.07% | +6.5% |
| Q1 2023 | $3,105,000 | -23.1% | 300,000 | -25.0% | 0.06% | -35.4% |
| Q4 2022 | $4,040,071 | +1.9% | 400,007 | 0.0% | 0.10% | +5.5% |
| Q3 2022 | $3,964,000 | +1.0% | 400,007 | 0.0% | 0.09% | +3.4% |
| Q2 2022 | $3,924,000 | +0.1% | 400,007 | 0.0% | 0.09% | +15.8% |
| Q1 2022 | $3,920,000 | -1.2% | 400,007 | 0.0% | 0.08% | -8.4% |
| Q4 2021 | $3,966,000 | – | 400,007 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 700,000 | $7,331,000 | 2.49% |
| Soleus Capital Management, L.P. | 300,000 | $3,142,000 | 0.57% |
| HealthCor Management, L.P. | 1,159,360 | $12,141,000 | 0.43% |
| Bain Capital Life Sciences Investors, LLC | 700,000 | $7,331,000 | 0.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $5,200,000 | 0.40% |
| Boxer Capital, LLC | 750,000 | $10,335,000 | 0.35% |
| Union Square Park Capital Management, LLC | 100,500 | $1,052,000 | 0.35% |
| Altium Capital Management LP | 100,000 | $1,047,000 | 0.29% |
| Consonance Capital Management LP | 250,000 | $2,618,000 | 0.28% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,000,000 | $10,473,000 | 0.23% |